Bcl-XL Is the primary mediator of p21 protection against hyperoxia-induced cell death

Experimental Lung Research

Volumn 37, Issue 2, 2011, Pages 82-91

  Wu, Yu Chieh M ^a   O'Reilly, Michael A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

apoptosis; Bcl 2 proteins; cell cycle inhibitor p21; hyperoxia; necrosis

Indexed keywords

BCL2 RELATED PROTEIN A1; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN MCL 1; PROTEIN P21;

ARTICLE; CARCINOMA CELL; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPEROXIA; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FAMILY;

ADENOCARCINOMA; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HUMANS; LUNG NEOPLASMS; OXYGEN; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING;

EID: 79951938593     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2010.521617     Document Type: Article

References (45)

1. Freeman BA, Crapo JD: Hyperoxia increases oxygen radical production in rat lungs and lung mitochondria. J Biol Chem. 1981;256:10986-10992.
2. Pagano A, Barazzone-Argiroffo C: Alveolar cell death in hyperoxia-induced lung injury. Ann N Y Acad Sci. 2003; 1010: 405-416. (Pubitemid 38265016)
3. Mantell LL, Horowitz S, Davis JM, Kazzaz JA: Hyperoxiainduced cell death in the lung - the correlation of apoptosis, necrosis, and inflammation. Ann N Y Acad Sci. 1999; 887: 171-180. (Pubitemid 30040228)
4. Barazzone C, Horowitz S, Donati YR, Rodriguez I, Piguet PF: Oxygen toxicity in mouse lung: pathways to cell death. Am J Respir Cell Mol Biol. 1998; 19: 573-581. (Pubitemid 128354238)
5. Budinger GR, Tso M, McClintock DS, Dean DA, Sznajder JI, Chandel NS: Hyperoxia-induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by Bcl-2 proteins. J Biol Chem. 2002; 277: 15654-15660. (Pubitemid 34967837)
6. Metrailler-Ruchonnet I, Pagano A, Carnesecchi S, Ody C, Donati Y, Barazzone Argiroffo C: Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway. Free Radic Biol Med. 2007; 42: 1062-1074. (Pubitemid 46356899)
7. Vitiello PF,Wu YC, Staversky RJ, O'Reilly MA: p21(Cip1) protects against oxidative stress by suppressing ER-dependent activation of mitochondrial death pathways. Free Radic Biol Med. 2009; 46: 33-41.
8. He CH, Waxman AB, Lee CG, Link H, Rabach ME, Ma B, Chen Q, Zhu Z, Zhong M, Nakayama K, Nakayama KI, Homer R, Elias JA: Bcl-2-related protein A1 is an endogenous and cytokine-stimulated mediator of cytoprotection in hyperoxic acute lung injury. J Clin Invest. 2005; 115: 1039-1048. (Pubitemid 40489409)
9. Nyunoya T, Monick MM, Powers LS, Yarovinsky TO, Hunninghake GW: Macrophages survive hyperoxia via prolonged ERK activation due to phosphatase down-regulation. J Biol Chem. 2005; 280: 26295-26302. (Pubitemid 41022227)
10. Wang X, Ryter SW, Dai C, Tang ZL, Watkins SC, Yin XM, Song R, Choi AM: Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. J Biol Chem. 2003; 278: 29184-29191. (Pubitemid 36935834)
11. Franek WR, Morrow DM, Zhu H, Vancurova I, Miskolci V, Darley-Usmar K, Simms HH, Mantell LL: NF-kappaB protects lung epithelium against hyperoxia-induced nonapoptotic cell death-oncosis. Free Radic Biol Med. 2004; 37: 1670-1679. (Pubitemid 39349813)
12. O'Reilly MA, Staversky RJ, Finkelstein JN,Keng PC: Activation of the G2 cell cycle checkpoint enhances survival of epithelial cells exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2003; 284: L368-L375.
13. Rancourt RC, Hayes DD, Chess PR, Keng PC, O'Reilly MA: Growth arrest in G1 protects against oxygen-induced DNA damage and cell death. J Cell Physiol. 2002; 193: 26-36. (Pubitemid 34969125)
14. Shenberger JS, Dixon PS: Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am J Respir Cell Mol Biol. 1999; 21: 395-402. (Pubitemid 129517194)
15. Helt CE, Rancourt RC, Staversky RJ, O'Reilly MA: p53-dependent induction of p21(Cip1/WAF1/Sdi1) protects against oxygen-induced toxicity. Toxicol Sci. 2001; 63: 214-222. (Pubitemid 32982795)
16. Gehen SC, Staversky RJ, Bambara RA, Keng PC, O'Reilly MA: hSMG-1 and ATM sequentially and independently regulate the G(1) checkpoint during oxidative stress. Oncogene. 2008; 27: 4065-4074.
17. McGrath-Morrow SA, Cho C, Soutiere S, Mitzner W, Tuder R: The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice. Am J Respir Cell Mol Biol. 2004; 30: 635-640.
18. Bissonnette N, HuntingDJ: p21-induced cycle arrest inG1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 1998; 16: 3461-3469. (Pubitemid 28349689)
19. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 1996; 10: 1945-1952. (Pubitemid 26281688)
20. Rancourt RC, Keng PC, Helt CE, O'Reilly MA: The role of p21(CIP1/WAF1) in growth of epithelial cells exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2001; 280: L617-L626.
21. GorospeM,Wang X, Guyton KZ, Holbrook NJ: Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell Biol. 1996; 16: 6654-6660. (Pubitemid 26389723)
22. Asada M, Yamada T, Ichijo H, Delia D, Miyazono K, Fukumuro K, Mizutani S: Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 1999; 18: 1223-1234. (Pubitemid 29110307)
23. Suzuki A, Tsutomi Y, Akahane K, Araki T, Miura M: Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 1998; 17: 931-939. (Pubitemid 28425403)
24. Xu SQ, El-Deiry WS: p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4. Biochem Biophys Res Commun. 2000; 269: 179-190.
25. Vitiello PF, Staversky RJ, Gehen SC, Johnston CJ, Finkelstein JN, Wright TW, O'Reilly MA: P21Cip1 protection against hyperoxia requires Bcl-XL and is uncoupled from its ability to suppress growth. Am J Pathol. 2006; 168: 1838-1847. (Pubitemid 43825304)
26. Staversky RJ, Vitiello PF,Gehen SC, HeltCE, Rahman A, Keng PC, O'Reilly MA: p21(Cip1/Waf1/Sdi1) protects against hyperoxia by maintaining expression of Bcl-X(L). Free Radic Biol Med. 2006; 41: 601-609.
27. Vitiello PF, Staversky RJ, Keng PC, O'Reilly MA: PUMA inactivation protects against oxidative stress through p21/Bcl-XL inhibition of bax death. Free Radic Biol Med. 2008; 44: 367-374.
28. Helt CE, Staversky RJ, Lee YJ, Bambara RA, Keng PC,O'Reilly MA: The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2004; 286: L506-L513. (Pubitemid 38233621)
29. Willis SN, Chen L, Dewson G, Wei A, Naik E, Fletcher JI, Adams JM, Huang DC: Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev. 2005; 19: 1294-1305. (Pubitemid 41003019)
30. O'Reilly MA, Staversky RJ, Huyck HL, Watkins RH, LoMonaco MB, D'Angio CT, Baggs RB, Maniscalco WM, Pryhuber GS: Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest. 2000; 80: 1845-1854.
31. Kim YG, Kim HJ, Kim DS, Kim SD, Han WS, Kim KH, Chung JH, Park KC: Up-regulation and redistribution of Bax in ultraviolet B-irradiatedmelanocytes. Pigment Cell Res. 2000; 13: 352-357.
32. Isenmann S, Wahl C, Krajewski S, Reed JC, Bahr M: Upregulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci. 1997; 9: 1763-1772. (Pubitemid 27348335)
33. Pearson AS, Spitz FR, Swisher SG, Kataoka M, Sarkiss MG, Meyn RE,McDonnell TJ, Cristiano RJ, Roth JA: Up-regulation of the proapoptotic mediators Bax and Bak after adenovirus-mediated p53 gene transfer in lung cancer cells. Clin Cancer Res. 2000; 6: 887-890. (Pubitemid 30159345)
34. Chirakkal H, Leech SH, Brookes KE, Prais AL,Waby JS, Corfe BM: Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene. 2006; 25: 7192-7200. (Pubitemid 44764188)
35. Morrison DJ, English MA, Licht JD: WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res. 2005; 65: 8174-8182. (Pubitemid 41330581)
36. Shimazu T, Degenhardt K, Nur EKA, Zhang J, Yoshida T, Zhang Y, Mathew R, White E, Inouye M: NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev. 2007; 21: 929-941. (Pubitemid 46625642)
37. Xu D, Perez RE, Ekekezie, II, Navarro A, Truog WE: Epidermal growth factor-like domain 7 protects endothelial cells from hyperoxia-induced cell death. AmJ Physiol Lung Cell Mol Physiol. 2008; 294: L17-L23. (Pubitemid 351380314)
38. Germain M, Milburn J, Duronio V: MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction. J Biol Chem. 2008; 283: 6384-6392.
39. Zhou P, Qian L, Kozopas KM, Craig RW: Mcl-1, a Bcl-2 family member, delays the death of hematopoietic cells under a variety of apoptosis-inducing conditions. Blood. 1997; 89: 630-643. (Pubitemid 27051700)
40. Vairo G, Soos TJ, Upton TM, Zalvide J, DeCaprio JA, Ewen ME, Koff A, Adams JM: Bcl-2 retards cell cycle entry through p27(Kip1), pRB relative p130, and altered E2F regulation. Mol Cell Biol. 2000; 20: 4745-4753. (Pubitemid 30396121)
41. Greider C, Chattopadhyay A, Parkhurst C, Yang E: BCL-x(L) and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene. 2002; 21: 7765-7775. (Pubitemid 35398834)
42. Mei Y, Du W, Yang Y, Wu M: Puma(*)Mcl-1 interaction is not sufficient to prevent rapid degradation ofMcl-1. Oncogene. 2005; 24: 7224-7237. (Pubitemid 41679284)
43. Czabotar PE, Lee EF, van Delft MF, Day CL, Smith BJ, Huang DC, Fairlie WD, Hinds MG, Colman PM: Structural insights into the degradation of Mcl-1 induced by BH3 domains. Proc Natl Acad Sci U S A. 2007; 104: 6217-6222. (Pubitemid 47186075)
44. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000; 288: 1053-1058. (Pubitemid 30324238)
45. Ming L, Wang P, Bank A, Yu J, Zhang L: PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells. J Biol Chem. 2006; 281: 16034-16042.